Information about Venture Management Concepts & Capital
My details
*
*
*
No warnings for this company
{{translate('company_activity_bron_' + bron)}}
Code Description
{{activiteit.code}} {{activiteit.description}}

Venture Management Concepts & Capital (SRL)

Company information

Status
Active

KVK number

28068425

VAT Number

Established
01-07-1986
Last balance sheet year
2023
Company size
Small 0 FTE
RSIN number
810400789
Commercial name
Antibiotica.app
Principal activity
Overige activiteiten van hoofdkantoren
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Venture Management Concepts & Capital

2023 2022 2021 2020
Equity -620.430 0 % -618.993 -87 % -331.688 -21 % -273.258
Employees 0 0 0 0

Frequently asked questions

What is the VAT number of Venture Management Concepts & Capital?
Log in or start a free trial to view the VAT number.
What is the KVK number of Venture Management Concepts & Capital?
The KVK number of Venture Management Concepts & Capital is 28068425
When was Venture Management Concepts & Capital founded?
Venture Management Concepts & Capital was founded on 01-07-1986.
What is the address of Venture Management Concepts & Capital?
The current registered office of Venture Management Concepts & Capital is located at Overdiemerweg 13, 1111 PN Diemen.
When was the last time Venture Management Concepts & Capital filed their annual financial statements?
The most recent financial statements of Venture Management Concepts & Capital were filed on 23-07-2025.
How many employees does Venture Management Concepts & Capital have?
There are currently no employees working at Venture Management Concepts & Capital or no workforce information is available.
What is the annual turnover of Venture Management Concepts & Capital?
There is no turnover available for Venture Management Concepts & Capital.